Yves Piette

dr. Yves Piette

Reumatologie

Case report.

Gent
08/11/2016

20th Belgian Congres on Rheumatology. Quiz.

Charleroi
28-30/09/2016

Rare cases of bone fragility or disorders (case reports).

La Hulpe
11-12/03/2016

Assessment of Sensitivity to Change of the Disease Activity Score (DAS) in Systemic Sclerosis (SSc).

Rome
01/02/2014

Four years follow-up of an open-label pilot study of treatment with rituximab in patients with early, diffuse cutaneous systemic sclerosis.

Brussel
01/01/2014

Two years follow-up results of a multicenter, open-label pilot study with rituximab in patients with early, diffuse cutaneous systemic sclerosis.

Brussel
01/01/2014

Stabilisation of microcirculation in patients with early systemic sclerosis with diffuse skin involvement treated with rituximab.

Oostende + San Diego
01/01/2013

Synovial fluid derived invariant Natural Killer T cells in chronic arthritides show an increased Programmed Death-1 expression and anerghic phenotype.

La Hulpe
01/01/2012

Two years follow-up results of an open pilot study of fixed repeated treatment with rituximab in patients with “early” systemic sclerosis with diffuse skin involvement.

Antwerpen + Chicago
01/01/2011